Observational Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Apr 26, 2020; 8(8): 1424-1443
Published online Apr 26, 2020. doi: 10.12998/wjcc.v8.i8.1424
Figure 6
Figure 6 Progression-free survival in the first-line chemotherapy setting in patients with final stage IV RAS-wild-type disease receiving panitumumab according to primary tumour location.